Header Logo

Connection

ANDREW CIVITELLO to Male

Back to Details
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Male.
ANDREW CIVITELLO
Connection Strength
0.299
Male
  1. Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J. 2009; 36(5):494-5.
    View in: PubMed
    Score: 0.012
  2. Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF-LVADs? Artif Organs. 2026 Jun; 50(6):886-890.
    View in: PubMed
    Score: 0.009
  3. Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen-Year Longitudinal Profile. Artif Organs. 2026 Apr; 50(4):572-579.
    View in: PubMed
    Score: 0.009
  4. Evolution of Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2026 Sep 01; 72(9):e222-e227.
    View in: PubMed
    Score: 0.009
  5. Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 02; 44(2):278-281.
    View in: PubMed
    Score: 0.009
  6. Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2025 10; 39(5):1085-1095.
    View in: PubMed
    Score: 0.009
  7. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 09; 10(9):2049-2058.
    View in: PubMed
    Score: 0.009
  8. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.008
  9. Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
    View in: PubMed
    Score: 0.007
  10. Continuous-Flow Left Ventricular Assist Device Explantation After More Than 5 Years of Circulatory Support and Ventricular Reconditioning. Tex Heart Inst J. 2021 06 10; 48(2).
    View in: PubMed
    Score: 0.007
  11. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.007
  12. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Circulation. 2021 04 27; 143(17):1673-1686.
    View in: PubMed
    Score: 0.007
  13. Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
    View in: PubMed
    Score: 0.007
  14. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.006
  15. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
    View in: PubMed
    Score: 0.006
  16. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.006
  17. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
    View in: PubMed
    Score: 0.006
  18. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.006
  19. Long-Term Continuous-Flow Left Ventricular Assist Device Support After Left Ventricular Outflow Tract Closure. ASAIO J. 2019 08; 65(6):558-564.
    View in: PubMed
    Score: 0.006
  20. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection. J Card Surg. 2019 Feb; 34(2):82-91.
    View in: PubMed
    Score: 0.006
  21. A left ventricular end-diastolic dimension less than 6.0?cm is associated with mortality after implantation of an axial-flow pump. J Thorac Cardiovasc Surg. 2019 06; 157(6):2302-2310.
    View in: PubMed
    Score: 0.006
  22. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
    View in: PubMed
    Score: 0.006
  23. A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail. 2018 Oct; 24(10):661-671.
    View in: PubMed
    Score: 0.006
  24. Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. ASAIO J. 2018 Sep-Oct; 64(5):594-600.
    View in: PubMed
    Score: 0.006
  25. Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support. Ann Thorac Cardiovasc Surg. 2021 Jun 20; 27(3):211-214.
    View in: PubMed
    Score: 0.006
  26. Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels. Ann Thorac Cardiovasc Surg. 2021 Feb 20; 27(1):64-67.
    View in: PubMed
    Score: 0.006
  27. Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
    View in: PubMed
    Score: 0.006
  28. Use of Remote Pulmonary Artery Pressure Monitoring (CardioMEMS System) in Total Artificial Heart to Assess Pulmonary Hemodynamics for Heart Transplantation. ASAIO J. 2018 Jul/Aug; 64(4):e75-e77.
    View in: PubMed
    Score: 0.006
  29. HeartMate II implantation technique that spares the sternum and ascending aorta. J Artif Organs. 2018 Dec; 21(4):458-461.
    View in: PubMed
    Score: 0.006
  30. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.006
  31. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
    View in: PubMed
    Score: 0.005
  32. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
    View in: PubMed
    Score: 0.005
  33. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
    View in: PubMed
    Score: 0.005
  34. Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
    View in: PubMed
    Score: 0.005
  35. Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
    View in: PubMed
    Score: 0.005
  36. Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol. 2018 02 01; 121(3):336-342.
    View in: PubMed
    Score: 0.005
  37. Left ventricular outflow tract closure during LVAD implantation: 2 cases of patients supported for over 6?years. J Artif Organs. 2017 Dec; 20(4):350-353.
    View in: PubMed
    Score: 0.005
  38. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs. 2018 Mar; 21(1):31-38.
    View in: PubMed
    Score: 0.005
  39. Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec 01; 120(11):1998-2002.
    View in: PubMed
    Score: 0.005
  40. Total artificial heart implantation for biventricular failure due to eosinophilic myocarditis. J Artif Organs. 2017 Sep; 20(3):266-269.
    View in: PubMed
    Score: 0.005
  41. Perforation of a HeartMate II outflow graft. J Card Surg. 2017 Mar; 32(3):233-234.
    View in: PubMed
    Score: 0.005
  42. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
    View in: PubMed
    Score: 0.005
  43. Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J. 2015 Feb; 42(1):40-3.
    View in: PubMed
    Score: 0.004
  44. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
    View in: PubMed
    Score: 0.004
  45. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014 Feb; 27(1):1-11.
    View in: PubMed
    Score: 0.004
  46. Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013 Nov 01; 112(9):1520-2.
    View in: PubMed
    Score: 0.004
  47. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
    View in: PubMed
    Score: 0.003
  48. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.003
  49. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006 Mar; 18(3):93-6.
    View in: PubMed
    Score: 0.002
  50. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
    View in: PubMed
    Score: 0.002
  51. DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet. 1991 Oct; 49(4):746-56.
    View in: PubMed
    Score: 0.001
  52. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics. 1990 Jun; 7(2):235-44.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.